Johnson & Johnson

JNJNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$648.721 B

$269.19 -0.10%

Close of 22 Sept 2026

Revenue

$94.2B

#39 by revenue

Earnings

$26.8B

#15 by earnings

Shares outstanding

2,409,898,597

Latest filing cover page

P/E ratio

24.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#1Eli Lilly & CoLLY$1.10T
#2Johnson & JohnsonJNJ$648.7B
#3AbbVieABBV$468.7B
#4Merck & Co.MRK$372.3B
#5NovartisNVS$269.6B

What if Johnson & Johnson were worth as much as…

Open the what-if tool →

Gold $30.2T

$12,545.74

Per share 46.6× higher

Bitcoin $1.74T

$722.71

Per share 2.68× higher

Nvidia $5.52T

$2,288.80

Per share 8.50× higher

Or at a round number

$1.00T $2.00T $5.00T $10.0T

Where these numbers come from

Share counts and financials for Johnson & Johnson are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.